← Back to guidelines
Cardiology5 papers

Congenital nasopharyngeal teratoma

Last edited: 4/23/2026

Overview

Congenital nasopharyngeal teratoma is a rare benign tumor originating from embryonic remnants in the nasopharynx, often presenting as a cystic mass protruding from the oral cavity in neonates 1.

Diagnosis

  • Elevated maternal serum alpha-fetoprotein levels 1
  • Prenatal ultrasound revealing a cystic mass in the mandibular or nasopharyngeal region 1
  • Postnatal clinical examination showing a mass protruding from the oral cavity 1
  • Imaging studies (ultrasound, MRI) to confirm location and extent 1
  • Management

  • Immediate neonatal airway management due to potential airway obstruction 1
  • Surgical excision as definitive treatment, often requiring multidisciplinary approach 1
  • Aggressive supportive care for coexisting anomalies (cardiac, respiratory) 1
  • Special Populations

  • Pregnancy: Monitor elevated alpha-fetoprotein levels and perform detailed prenatal imaging to assess fetal condition 1
  • Pediatrics: Focus on securing airway and addressing immediate life-threatening issues before definitive surgical intervention 1
  • Key Recommendations

  • Recognize elevated maternal alpha-fetoprotein and prenatal cystic masses as indicators for potential nasopharyngeal teratoma (Evidence: Moderate 1)
  • Prepare for urgent neonatal airway management due to the risk of obstruction (Evidence: Expert opinion 1)
  • Prioritize surgical excision post-stabilization for definitive treatment (Evidence: Expert opinion 1)
  • References

    1 Marras T, Poenaru D, Kamal I. Perinatal management of nasopharyngeal teratoma. The Journal of otolaryngology 1995. link

    Original source

    1. [1]
      Perinatal management of nasopharyngeal teratoma.Marras T, Poenaru D, Kamal I The Journal of otolaryngology (1995)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG